Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | 225Ac-PSMA-R2 |
Synonyms | |
Therapy Description |
Limited information is currently available on 225Ac-PSMA-R2, a putative radioligand therapy targeting PSMA (Nov 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
225Ac-PSMA-R2 | Limited information is currently available on 225Ac-PSMA-R2, a putative radioligand therapy targeting PSMA (Nov 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05983198 | Phase Ib/II | 225Ac-PSMA-R2 | A Phase I/II, Open-label, Multi-center Study of [225Ac]Ac-PSMA-R2 in Men With PSMA-positive Prostate Cancer With or Without Prior 177Lu-PSMA Radioligand Therapy. | Recruiting | FRA | 0 |